WaferGen Bio Profile

6.90
USD 0.00  0.00%
0%
0%

WaferGen Bio exotic insider transaction detected

WaferGen Bio systems insider trading alert for general transaction of common stock by Shivji Alnoor, Chief Executive Officer, on July 14, 2018. This event was filed by Wafergen Biosystems Inc with SEC on 2010-04-09. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

WaferGen Bio Summary

WaferGen Bio systems (WGBS) is traded on Nasdaq Capital Markets in USA. It is located in WaferGen Biosystems, Inc.Fremont, CA and employs 55 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 26.22 M. WaferGen Bio systems has 3.8 M outstanding shares of which 240.41 K shares are at this time shorted by private and institutional investors with about 0.0 trading days to cover. WAFERGEN BIO-SYST currently holds about 5.15 M in cash with (13.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Check WaferGen Bio Probability Of Bankruptcy

Ownership Allocation (%)

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Sabby Management LlcCommon Shares358.5 K1.8 M
Opaleye Management IncCommon Shares320 K1.6 M
View WaferGen Bio Diagnostics

Key Fundamentals

WaferGen Bio Against Markets

Current Ratings

WaferGen Bio 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
95 
Equity ratings for WaferGen Bio systems are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific. more
NameWaferGen Bio systems
CEO and President and DirectorRolland CarlsonView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressWaferGen Biosystems, Inc.Fremont, CA
ExchangeNasdaq Capital Markets
IndustryMeasuring and Control Equipment
BenchmarkDOW
Websitewww.wafergen.com
Phone510 651 4450
CurrencyUSD - US Dollar

WaferGen Bio Corporate Directors

Makoto Kaneshiro Independent Director
Robert Schueren Director
Joel Kanter Lead Independent Director
See also Your Current Watchlist. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">